Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Income towards Parent Company (2018 - 2025)

Historic Income towards Parent Company for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to -$21.1 million.

  • Neurogene's Income towards Parent Company fell 365.48% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 2393.35%. This contributed to the annual value of -$75.7 million for FY2024, which is 4376.38% down from last year.
  • Per Neurogene's latest filing, its Income towards Parent Company stood at -$21.1 million for Q3 2025, which was down 365.48% from -$23.2 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Income towards Parent Company ranged from a high of -$11.9 million in Q2 2023 and a low of -$23.2 million during Q2 2025
  • In the last 3 years, Neurogene's Income towards Parent Company had a median value of -$18.6 million in 2024 and averaged -$17.8 million.
  • As far as peak fluctuations go, Neurogene's Income towards Parent Company tumbled by 5713.92% in 2024, and later crashed by 365.48% in 2025.
  • Quarter analysis of 3 years shows Neurogene's Income towards Parent Company stood at -$14.0 million in 2023, then plummeted by 40.71% to -$19.7 million in 2024, then dropped by 7.35% to -$21.1 million in 2025.
  • Its Income towards Parent Company stands at -$21.1 million for Q3 2025, versus -$23.2 million for Q2 2025 and -$22.8 million for Q1 2025.